The accuracy of self-reported blood pressure in the ication adherence mprovement upport pp or ngagement–lood ressure (MedISAFE-BP) trial: Implications for pragmatic trials - 05/02/20
Abstract |
Self-report of health conditions and behaviors is one potential strategy to increase the pace of enrollment into pragmatic clinical trials. In this study, we assessed the accuracy of self-reported poorly controlled hypertension among adults in the community who were screened for participation in the MedISAFE-BP trial. Of individuals who self-reported poorly controlled hypertension using the online trial enrollment platform, 64% had a systolic blood pressure less than 140 mm Hg when measured at home. Although we identified several characteristics associated with accurate self-report including older age (odds ratio [OR] 1.02 per year, 95% CI 1.01-1.03), diabetes (OR 1.59, 95% CI 1.17-2.14), and low health activation (OR 1.56 95% CI 1.17-2.07), we were unable to identify patients for whom self-reported hypertension would be a reliable method for their inclusion in a pragmatic trial.
Le texte complet de cet article est disponible en PDF.Plan
| Funding: The MedISAFE-BP trial was supported by an unrestricted grant from Medisafe Inc. |
Vol 220
P. 68-72 - février 2020 Retour au numéro
Article précédent
- The effect of metoprolol and aspirin on cardiovascular risk in bereavement: A randomized controlled trial
- Geoffrey H. Tofler, Marie-Christine Morel-Kopp, Monica Spinaze, Jill Dent, Christopher Ward, Sharon McKinley, Anastasia S. Mihailidou, Jennifer Havyatt, Victoria Whitfield, Roger Bartrop, Judith Fethney, Holly G. Prigerson, Thomas Buckley
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?